Clinical Trial

Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

Study acronym: CRS/HIPEC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 23, 2022 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-09-27; most recent amendment 2022-08-19.
Trial Details
NCT Number NCT04108936
Lead Sponsor University of Regensburg
Collaborators: Krankenhaus Barmherzige Brüder, Regensburg
Conditions Peritoneal Carcinomatosis
Enrollment 250 participants
Start Date 2016-10
Primary Completion 2026-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2022-08-23